Status:
COMPLETED
Comparative Pain Control Between 0.2 or 0.3 Spinal Morphine and 0.25 or 0.5 % Bupivacaine for FNB After TKA
Lead Sponsor:
Mahidol University
Collaborating Sponsors:
Siriraj Hospital
Conditions:
Post Operative Pain
Total Knee Replacement
Eligibility:
All Genders
45-75 years
Phase:
PHASE4
Brief Summary
Comparative efficacy of 24 and 48 hours post operative pain control in single total knee replacement between intrathecal bupivacaine with 0.2 or 0.3 mg morphine together with 0.25 or 0.5 % bupivacaine...
Eligibility Criteria
Inclusion
- Single elective total knee replacement in ASA 1-3 without significant cardiovascular limitation
Exclusion
- patient at risk in usage COX-2 for post operative pain control
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00795223
Start Date
October 1 2008
End Date
May 1 2009
Last Update
September 29 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Siriraj Hospital
Bangkok, Bangkoknoi, Thailand, 10700